Claudin-1 Mediated Tight Junction Dysfunction as a Contributor to Atopic March.

Area of Science:

• Immunology and Dermatology
• Molecular Biology
• Gastroenterology and Pulmonology

Background:

• Atopic march describes the sequential development of allergic diseases, typically starting with atopic dermatitis and progressing to asthma and food allergies.
• The underlying mechanisms for allergic inflammation spreading from the skin to the gastrointestinal tract and airways remain unclear.
• A compromised skin barrier is a suspected risk factor for developing allergic sensitization.

Purpose of the Study:

• To investigate the role of claudin-1 in the pathogenesis of atopic march.
• To test the hypothesis that impaired claudin-1 expression and subsequent tight junction dysfunction contribute to atopic march.

Main Methods:

• Examined claudin-1 expression levels in epithelial tissues (skin, bronchial, intestinal) of patients with atopic dermatitis, asthma, and food allergy.
• Utilized mouse models of atopic dermatitis and allergic asthma to assess the impact of claudin-1 knockdown on allergic inflammation.
• Analyzed the association between CLDN-1 gene polymorphism, claudin-1 expression, and epithelial barrier function.

Main Results:

• Claudin-1 expression was significantly downregulated in the skin, bronchial, and intestinal epithelia of patients with atopic dermatitis, asthma, and food allergy.
• Knockdown of claudin-1 in mouse models exacerbated allergic inflammation in atopic dermatitis and asthma.
• Downregulation of claudin-1 expression was linked to impaired epithelial barrier function across multiple organs.

Conclusions:

• Reduced claudin-1 expression and resulting tight junction dysfunction are implicated in the development of atopic march.
• Impaired claudin-1 levels may serve as a risk factor and potential diagnostic marker for atopic march.
• Claudin-1 represents a promising therapeutic target for mitigating the progression of atopic march.